eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | muscular atrophy |
| Comorbidity | C0235974|pancreatic carcinoma |
| Sentences | 1 |
| PubMedID- 20233404 | More recently, this agent has been reported to act as a proteasome inhibitor, blocking proteolysis and muscle wasting in patients with pancreatic carcinoma [13], reducing proteasomal activation in an animal model of sepsis [14], and reducing the resting level of cytokines [15]. |
Page: 1